• GAAPP SUMMIT & ANNUAL GENERAL MEETING 2026

    GAAPP SUMMIT & ANNUAL GENERAL MEETING 2026

    GAAPP SUMMIT 2026 The GAAPP Summit provides the platform for patient organizations to raise their voice for urgent issues, share best practices, and come together with respiratory and immunology advocacy organizations. Strengthening the impact of patient organizations requires a dedicated space for high-level collaboration, strategic planning, and the sharing of transformative insights.  The GAAPP Summit… Read More >

  • Global Pulmonary Hypertension Patient Hackathon 2026

    Global Pulmonary Hypertension Patient Hackathon 2026

    The Global Allergy & Airways Patient Platform (GAAPP) and Latin Health Leaders are proud to announce the Global Pulmonary Hypertension Patient Hackathon, taking place on June 10–11, 2026, in Dallas, Texas, which will be held in conjunction with the PHA 2026 International Conference (June 11–14). This landmark event brings together patient leaders, clinical experts, and… Read More >

  • World Asthma May 2026

    World Asthma May 2026

    We are all woven together! In alignment with the Global Initiative for Asthma (GINA) theme for World Asthma Day, the Global Allergy & Airways Patient Platform has launched its 2026 campaign, “We Are All Woven Together.” At the heart of this initiative is a global asthma testimonial map, designed to amplify patient voices across countries… Read More >

  • The Inaugural NAA Regional Meeting 2026

    The Inaugural NAA Regional Meeting 2026

    NAA MEETING 2026 Recognizing the unique healthcare landscape of the United States and Canada, the Global Allergy & Airways Patient Platform (GAAPP) is proud to highlight the newest addition to its global network: the North America Alliance (NAA).  Established in early 2026, the NAA is GAAPP’s youngest alliance, born from a need to better synchronize… Read More >

  • AMEA MEETING 2026

    AMEA MEETING 2026

    AMEA MEETING 2026 Respiratory diseases pose a significant health challenge globally, but their impact is felt with particular intensity across Africa and the Middle East. The urgent need for a unified, patient-centered approach has been magnified by the rising prevalence of asthma and COPD, coupled with persistent environmental triggers and limited access to specialized care. … Read More >

  • EEA MEETING 2026

    EEA MEETING 2026

    EEA MEETING 2026 The landscape of respiratory and allergic health in Europe is evolving rapidly. While the region benefits from robust healthcare frameworks, significant challenges remain regarding equitable treatment access, environmental health policy, and the integration of the patient voice into clinical decision-making.  In response to these needs, the Global Allergy & Airways Patient Platform… Read More >

  • SAREAL 2026

    SAREAL 2026

    SAREAL 2026 AAcross Latin America, the prevalence of respiratory and allergic diseases continues to present a significant public health challenge.   A unified strategy prioritizing the patient experience is essential to address regional healthcare inequities and the growing influence of urban environmental factors  To address these evolving needs, the Global Allergy & Airways Patient Platform (GAAPP),… Read More >

  • APAC MEETING 2026

    APAC MEETING 2026

    APAC MEETING 2026 The Asia-Pacific region is home to some of the world’s most diverse healthcare landscapes and a significant portion of the global population living with respiratory, allergic, and atopic conditions. From navigating environmental health challenges to addressing disparities in medical access, the regional need for a coordinated patient-advocacy effort is more vital than… Read More >

  • Statement from the Global Allergy & Airways Patient Platform (GAAPP) regarding the impact of conflict on patient care

    Statement from the Global Allergy & Airways Patient Platform (GAAPP) regarding the impact of conflict on patient care

    The Global Allergy & Airways Patient Platform (GAAPP) stands as a worldwide advocate for millions of individuals living with allergies, asthma, and chronic airway and atopic diseases. Our mission is fundamentally rooted in the belief that every person, regardless of geography or circumstance, has the right to access essential medical care and live in an… Read More >

  • GAAPP Expands International Leadership Team to Drive Global Patient-Centered Research and Advocacy

    GAAPP Expands International Leadership Team to Drive Global Patient-Centered Research and Advocacy

    FOR IMMEDIATE RELEASE GAAPP Expands International Leadership Team to Drive Global Patient-Centered Research and Advocacy VIENNA, 25 March, 2026 — The Global Allergy & Airways Patient Platform (GAAPP) announced a major expansion of its international leadership team today, appointing eight world-class patient advocates across six countries. This strategic growth is designed to fortify the organization’s four… Read More >

  • Advocacy Beyond Borders: A New Global Partnership to Elevate the Airways Patient Voice and Experience

    Advocacy Beyond Borders: A New Global Partnership to Elevate the Airways Patient Voice and Experience

    We’re thrilled to share the exciting news of a powerful new alliance aimed at strengthening global patient care for people living with chronic respiratory diseases. In the Advocacy Beyond Borders video, GAAPP teams up with EUFOREA, a leader in medical innovation and science, to expand upon our shared missions of bridging gaps in information, improving… Read More >

  • World COPD Day 2025

    World COPD Day 2025

    COPD affects 391 million people worldwide—that’s equivalent to the population of 47 New York Cities or 44 Londons, 10 Tokyos, or 28 Rio De Janeiros. Yet despite its massive impact, COPD continues to be underprioritised, underfunded, and undertreated across healthcare systems globally. 1 This #WorldCOPDDay (19 November), we are urging healthcare providers and policymakers to… Read More >